Latest stroke Stories
Commercial activities ahead of schedule following release of strong clinical data in the multi-specialty CARENET trial BOSTON, Oct.
Icahn School of Medicine at Mount Sinai research findings show there was no significant difference in 15-year survival or stroke rates in patients aged between 50 and 69 years who had aortic valve
Stroke Survivor will Focus on Building Awareness and Strategic Growth to Expand Organization's 30-Year Legacy CENTENNIAL, Colo., Sept.
LEXINGTON, Ky., Sept.
AMBLER, Pa., Sept.
Additional New Features Help Patients and Physicians Monitor and Manage Heart Health SAN FRANCISCO, Sept.
Wright & Schulte LLC Continues To Investigate Complaints That Janssen Pharmaceuticals Did Not Disclose The Lack of An Effective Means To Treat Uncontrolled Bleeding In Patients Taking Xarelto
OSAKA, Japan, Sept. 26, 2014 /PRNewswire/ -- Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc.
Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.
More Images (3 images) »